Senator questions FDA, Synthes on possible conflicts of interest

02/27/2008 | NYTimes.com

The FDA and Synthes, maker of the Prodisc artificial spinal disc, received letters of inquiry from Sen. Charles E. Grassley, R-Iowa, regarding possible conflicts of interest among doctors connected to the clinical trials of the device. A Synthes spokesman said the company will cooperate in the inquiry, while an FDA spokeswoman said the agency does not comment on pending requests.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA